Home
nChroma Bio

nChroma Bio Market Share Analysis for November 2025

Industry: N/A

Domainnchromabio.com

Year Founded2024

Employees51 - 200

Annual Revenue--

nChroma Bio

nChroma Bio (including company regionals)

nchromabio.com

See more website traffic and engagement information

Total visits to nChroma Bio's top domains

Understand nChroma Bio market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

nchromabio.com3.7K

See more with Sales Intelligence

Avg. visit duration in nChroma Bio's top domains

Analyze nChroma Bio engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

nchromabio.com00:00:31

See more with Sales Intelligence

Avg. pageviews on nChroma Bio's top domains

See how nChroma Bio keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

nchromabio.com1.74

See more with Sales Intelligence

nChroma Bio top competitors by domain

Top similar sites in November 2025, ranked by their affinity

prometrika.comCompany NamePROMETRIKAEmployees51 - 200HQUnited States, Massachusetts, CambridgeAnnual revenue$10M - $15MTotal visits3.7KHealth > Biotechnology and Pharmaceuticals

Top technologies used by nChroma Bio

These are the website technologies, by industry, used by nChroma Bio top domains

Content Management System (3)

WordPress

Mobile (2)

Meta Viewport

Business Solutions (1)

DocuSign

Email Services (1)

Microsoft Exchange Online

More Technologies

6

See all

News & Signals from nChroma Bio

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsData Collective invests into Chroma Medicine, Inc. $75M in funding round.DCVC Bio participated in a fresh $75 million funding round for Chroma Medicine as it merged with Nvelop to form nChroma Bio, which will combine epigenetic editing capabilities with in vivo delivery technologies.

NewsChroma Medicine, Inc. received financing of $125M in Series A on Jan 1st '21.Chroma Medicine Inc. officially launched in 2021 with $125 million in series A funding and has since raised a $135 million series B. Chroma is among a small but emerging set of companies looking to modify the epigenome, which holds the promise of precise control of gene expression, but without directly cutting or mutating DNA and the safety risks that come with those approaches...

NewsKaplan leaves Chroma Medicine, Inc. as president, chief financial and corporate development officer.Kaplan comes from epigenetic medicine company Chroma Medicine, where he served as president, chief financial and corporate development officer.